Reframe Cancer, the specialist cancer navigation provider, has appointed Denise Wond as marketing director.

She will lead the firm’s marketing function and report directly to chief executive Mark Stephenson.

Wond (pictured) has held senior marketing positions at Royal London, Scottish Provident, Bright Grey, British Friendly Society and Scottish Power.

Her appointment comes during a period of expansion for Reframe, following several new client wins this year including Zurich, Benenden Health and Freedom Health Insurance.

She will be responsible for communicating Reframe’s growing body of evidence and outcome data, highlighting its expertise across the cancer pathway and strengthening awareness of the brand across its core markets.

Wond said: “I’m absolutely thrilled to join the Reframe team and to shape our marketing strategy as we go forward into a period of sustained growth.

“I know how difficult it is to navigate life with cancer, and I’m honoured to be part of a team that does such a fantastic job in helping people through that journey.”

Stephenson added: “We’re delighted to have secured someone of Denise’s calibre. Her background in the insurance, financial services and energy sectors speaks for itself.

“She is the perfect person to bring her passion and expertise to the role and communicate the amazing difference we make for cancer patients for our customers and partners.

“She will lead the communication of our evidence, data and clinical excellence and solutions that sets Reframe Cancer apart from others.”

The appointment follows a series of senior hires at Reframe Cancer, including Russell Young as commercial director, Professor Ben Kelly, formerly of Nuffield Health, as chief operating officer, and Nikki Cannon, previously head of personalised care and survivorship at Guy’s and St Thomas’ NHS Trust, as head of screening.

The investment in senior expertise follows Reframe’s recent Care Quality Commission approval.